NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 105509 | Null | 0.0228801759885691 | 0.30871122 |
NSC 182986 | AZQ | 0.0228801759885691 | 0.084255459 |
NSC 291049 | Null | 0.0228801759885691 | -0.10783333 |
NSC 294979 | BLEOMYCIN-BAPP | 0.0228801759885691 | 0.26065732 |
NSC 339638 | 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt | 0.0228801759885691 | -0.19820299 |
NSC 348121 | 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- | 0.0228801759885691 | -0.33311901 |
NSC 632831 | Null | 0.0228801759885691 | -0.3980363 |
NSC 634398 | Null | 0.0228801759885691 | 0.17653027 |
NSC 641233 | 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- | 0.0228801759885691 | -0.20113652 |
NSC 644916 | ANTINEOPLASTIC-644916 | 0.0228801759885691 | -0.18213695 |